To address whether there was any potential clinical significance in the levels of PRMT5 and E2F1, we examined gene expression in a collection of 649 human neuroblastoma biopsies taken from early and late (stage 1 to 4) disease and calculated survival probability curves [35]. Here, E2F1 is linked to neuroblastoma.